When should antithrombotics be restarted after GI bleeding?

Clinical takeaway: After the acute GI bleed is controlled, consider restarting indicated antiplatelet or anticoagulant therapy within 7 days, with timing individualized to bleeding severity, thrombotic risk, treatment indication, and the specific agent.

Clinicians must balance recurrent bleeding against stroke, MI, thromboembolism, and death after an antithrombotic-associated GI bleed. These pooled data support timely resumption once hemostasis is achieved.

A systematic review and meta-analysis of 21 studies involving 18,622 patients found that resuming antithrombotic therapy after GI bleeding generally produced a favorable clinical trade-off: modestly more recurrent bleeding, but fewer major vascular events and deaths.

At 1 year, restarting antiplatelet therapy was associated with recurrent GI bleeding in 7.7% of patients versus 5.5% with nonresumption, an absolute increase of 2.2 percentage points. However, major vascular events fell from 12.5% to 8.9%, and mortality dropped from 18.8% to 8.8%.

Anticoagulant resumption showed a similar pattern. Recurrent GI bleeding occurred in 7.2% versus 4.6%, while major vascular events declined from 13.2% to 6.2% and mortality from 25.6% to 14.5%.

Timing also mattered. Compared with restarting after 7 days, resumption within 7 days increased recurrent bleeding from 5.7% to 8.4%, but reduced major vascular events from 19.6% to 8.2%. Mortality was numerically lower with early resumption, although the difference was uncertain.

The authors concluded that antithrombotic medications “should be resumed as early as possible after the acute episode of gastrointestinal bleeding is under control.” They cautioned that most evidence came from retrospective cohorts, with only one randomized trial, and that optimal timing remains dependent on individual bleeding and thrombotic risk.

Source: Liu Y, et al. (2026 July 10) Clin Gastroenterol Hepatol. Timing of Antiplatelet and Anticoagulant Therapy Resumption Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis